Consolidated Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Consolidated Statements Of Operations [Abstract]
Net sales	$ 210,841	$ 264,484	$ 972,587	$ 1,076,944
Cost of goods sold:
Cost of sales	119,205	136,643	538,115	562,220
Depreciation related to cost of goods sold	1,967	1,656	5,784	4,674
Total cost of goods sold	121,172	138,299	543,899	566,894
Gross profit	89,669	126,185	428,688	510,050
Operating expenses:
Selling, general and administrative	107,338	111,597	365,713	404,257
Depreciation and amortization	11,286	10,254	33,122	28,755
Total operating expenses	118,624	121,851	398,835	433,012
(Loss) income from operations	(28,955)	4,334	29,853	77,038
Interest expense, net	6,605	5,893	18,371	18,515
(Loss) income before income taxes	(35,560)	(1,559)	11,482	58,523
(Benefit from) provision for income taxes	(8,626)	(286)	2,172	12,803
Net (loss) income	(26,934)	(1,273)	9,310	45,720
Net loss attributable to noncontrolling interests (See Note 5)	(491)		(897)
Net (loss) income attributable to Elizabeth Arden shareholders	$ (26,443)	$ (1,273)	$ 10,207	$ 45,720
Net (loss) income per common share attributable to Elizabeth Arden shareholders:
Basic	$ (0.89)	$ (0.04)	$ 0.34	$ 1.54
Diluted	$ (0.89)	$ (0.04)	$ 0.34	$ 1.50
Weighted average number of common shares:
Basic	29,697	29,607	29,664	29,658
Diluted	29,697	29,607	30,173	30,498